pGX28哺乳動物表達載體DNA疫苗基因治療質粒CMV啟動子Kan抗性

vectors having optimal conditions for gene therapy and DNA vaccination, and more particularly to eukaryotic expression vectors developed by combining various components. Further, the present invention relates to a pGX27 vector and a pGX28 vector capable of highly inducing the expression of the interleukin-12 variant gene when the interleukin-12 variant gene is inserted into various eukaryotic cell expression vectors of the present invention. The optimal vector of the present invention may be useful for gene therapy or DNA vaccination by inserting a target gene.
Plasmid, eukaryotic expression vector, gene therapy, DNA vaccine, interleukin-12 variant, pGX27, pGX28

Supplier來源:BioVector NTCC Inc.
TEL電話:+86-010-53513060
Website網址: http://www.biovector.net